Clinical Trial Update: Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of Sancuso (granisetron transdermal) and IV granisetron in children aged 6 to 12 with chemotherapy-induced nausea and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Granisetron (granisetron)
• SANCUSO (GRANISETRON)

Snippet

Sponsor: Kyowa Kirin Pharmaceutical Development Ltd | Conditions: Chemotherapy Induced Nausea and Vomiting | Phase 1 | Status: WITHDRAWN